New federal rules are changing the landscape for cannabinoid health products by tightening limits on THC in CBD. What happens when CBD is treated as true medicine? Dr. Priyanka Sharma, a chemical engineer and Co-CEO of Kazmira Therapeutics is leading innovation in high-purity, non-intoxicating cannabinoids. She breaks down what these changes mean for safety, patient care and the future of personalized CBD therapeutics.